This is the authors' abstract. We don't add key points for this paper.
ABVD regimen (doxorubicin, bleomycin, vinblastine and dacarbazine) remains the most commonly used front-line therapy for Hodgkin lymphoma. However, atypical and extranodal presentations present challenges to initial therapy, especially in the presence of renal and liver failure. We hereby present two cases of young male patients with atypical presentation of Hodgkin lymphoma with severe abnormal liver function. Patients showed excellent response to cyclophosphamide, etoposide, procarbazine and prednisone (CEPP regimen).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Thakar et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: